Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma, Cancer, vol.32, issue.1, pp.1-11, 1976. ,
DOI : 10.1002/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the multiinstitutional osteosarcoma study, Clin Orthop, vol.270, pp.8-14, 1991. ,
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group., Journal of Clinical Oncology, vol.15, issue.1, pp.76-84, 1997. ,
DOI : 10.1200/JCO.1997.15.1.76
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes, Science, vol.233, issue.4770, pp.1318-1321, 1986. ,
DOI : 10.1126/science.3489291
Lysis of Autologous Melanoma Cells by Tumor*Infiltrating Lymphocytes: Association With Clinical Response, JNCI Journal of the National Cancer Institute, vol.83, issue.13, pp.932-937, 1991. ,
DOI : 10.1093/jnci/83.13.932
Progress in human tumour immunology and immunotherapy, Nature, vol.411, issue.6835, pp.380-384, 2001. ,
DOI : 10.1038/35077246
Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients, Journal of Immunotherapy, vol.26, issue.4, pp.332-342, 2003. ,
DOI : 10.1097/00002371-200307000-00005
Tumor infiltrating lymphocytes and continous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinoma, Tumori, vol.86, pp.46-52, 2000. ,
Survival, Persistence, and Progressive Differentiation of Adoptively Transferred Tumor-Reactive T Cells Associated with Tumor Regression, Journal of Immunotherapy, vol.28, issue.3, pp.258-267, 2005. ,
DOI : 10.1097/01.cji.0000158855.92792.7a
Generation of diverse mutated tumor antigen-specific cytotoxic T lymphocytes in a lung cancer patient with long survival, Oncol Rep, vol.14, pp.763-769, 2005. ,
Tumor-Infiltrating Lymphocytes and Interleukin-2: Dose and Schedules of Administration in the Treatment of Metastatic Cancer, Cancer Biotherapy & Radiopharmaceuticals, vol.19, issue.6, pp.730-737, 2004. ,
DOI : 10.1089/cbr.2004.19.730
Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma, BJU International, vol.80, issue.4, pp.543-547, 1997. ,
DOI : 10.1046/j.1464-410X.1997.00408.x
Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer, European Journal of Cancer, vol.35, issue.5, pp.721-726, 1999. ,
DOI : 10.1016/S0959-8049(99)00033-7
CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma, European Journal of Surgical Oncology (EJSO), vol.30, issue.1, pp.53-57, 2004. ,
DOI : 10.1016/j.ejso.2003.10.001
Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast, Mod Pathol, vol.12, pp.1050-1056, 1999. ,
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer, Proceedings of the National Academy of Sciences, vol.12, issue.5 ,
DOI : 10.1016/S0952-7915(00)00147-3
Expression of MAGE genes in osteosarcoma, Journal of Orthopaedic Research, vol.64, issue.1, pp.128-132, 1997. ,
DOI : 10.1002/jor.1100150119
Expression of the SART1 tumor-rejection antigen in human osteosarcomas., International Journal of Oncology, vol.17, pp.29-32, 2000. ,
DOI : 10.3892/ijo.17.1.29
Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides, Journal of Orthopaedic Research, vol.88, issue.3, pp.346-351, 2001. ,
DOI : 10.1016/S0736-0266(00)90031-7
Identification of Human Autologous Cytotoxic T-Lymphocyte-Defined Osteosarcoma Gene That Encodes a Transcriptional Regulator, Papillomavirus Binding Factor, Cancer Research, vol.64, issue.15, pp.5442-5448, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0522
Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides, Clin Cancer Res, vol.7, pp.3950-3962, 2001. ,
HEAT-SHOCK PROTEIN 72 IN HUMAN OSTEOSARCOMA: T-Lymphocyte Reactivity and Cytotoxicity, Pediatric Hematology and Oncology, vol.87, issue.5, pp.355-364, 2000. ,
DOI : 10.1080/08880010050034283